Foghorn Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Foghorn Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q4 2024.
  • Foghorn Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 55.6M shares, a 31.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 55.6M +13.3M +31.5% Dec 31, 2024 10-K 2025-03-06
Q3 2024 55.6M +13.4M +31.7% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 55.3M +13.5M +32.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 42.6M +761K +1.82% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 42.3M +479K +1.15% Dec 31, 2023 10-K 2025-03-06
Q3 2023 42.2M +418K +1% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 41.9M +225K +0.54% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 41.8M +395K +0.95% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 41.8M +504K +1.22% Dec 31, 2022 10-K 2024-03-07
Q3 2022 41.8M +4.75M +12.8% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 41.6M +4.77M +12.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 41.4M +4.6M +12.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 41.3M +4.51M +12.3% Dec 31, 2021 10-K 2023-03-09
Q3 2021 37M +31M +515% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 36.9M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 36.8M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 36.8M +31.9M +655% Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 6.02M Sep 30, 2020 10-Q 2020-12-04
Q4 2019 4.87M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.